MAPT and Alzheimer disease: Use of a tau oligomer-specific antibody in human AD brain samples revealed that tau oligomers appear at early stages in AD, either before or after the manifestation of tau phosphorylation at specific epitopes (Lasagna-Reeves et al., 2012).